[Federal Register Volume 91, Number 36 (Tuesday, February 24, 2026)]
[Notices]
[Pages 8896-8897]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2026-03684]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Interagency Autism
Coordinating Committee.
The meeting will be open to the public to attend in person or
virtually. Virtual viewing will be accessible via NIH Videocast.
Advanced registration is required for in-person attendance; REAL ID or
equivalent is required for in-person attendance. Individuals wishing to
participate in person or virtually and in need of special assistance or
other reasonable accommodations should submit a request to the Contact
Person listed on this notice at least seven (7) business days prior to
the meeting. The open session can be accessed from the NIH Videocast
website (https://videocast.nih.gov/).
The purpose of the IACC meeting is to discuss committee business,
agency updates, and issues related to autism research and services
activities.
Name of Committee: Interagency Autism Coordinating Committee.
Date: March 19, 2026.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To discuss committee business, updates, and issues
related to autism research and services activities.
Address: National Institutes of Health, Neuroscience Center,
6001 Executive Boulevard, First Floor Conference Room, Rockville, MD
20852.
Meeting Format: In Person and Virtual Meeting.
Cost: The meeting is free and open to the public.
Registration: A registration web link will be posted on the IACC
website (iacc.hhs.gov) prior to the meeting. Pre-registration is
required for in-person attendance.
Deadlines: Public Comment Due Date: Thursday, March 5, by 5:00
p.m. ET, Public Comment Guidelines, For public comment instructions,
see below.
Contact Person: Ms. Rebecca Martin, Office Autism Research
Coordination, National Institute of Mental Health, NIH, Phone: 301-
435-0886, Email: [email protected].
Public Comments: The IACC welcomes written and oral/virtual
public comments from members of the autism community and asks the
community to review and adhere to its Public Comment Guidelines. In
the 2021-2023 IACC Strategic Plan, the IACC lists the ``Spirit of
Collaboration'' as one of its core values, stating that, ``We will
treat others with respect, listen with open minds to the diverse
lived experiences of people on the autism spectrum and their
families, consider multiple solutions, and foster discussions where
participants can comfortably share different opinions.'' In keeping
with this core value, the IACC and the NIMH Office of National
Autism Coordination (ONAC) ask that members of the public who
provide public comments or participate in meetings of the IACC also
adhere to this core value.
A limited number of slots are available for individuals to
provide a ~3-minute summary or excerpt of their written comment to
the Committee during the meeting either in person or via
videoconference. For those interested in that opportunity, please
indicate ``Interested in providing oral/virtual comment'' in your
written submission, along with your name, address, email, phone
number, and professional/organizational affiliation so that ONAC
staff can contact you if a slot is available.
For any given meeting, priority for comment slots will be
assigned to individuals and organizations that have not previously
provided comments in the current calendar year. This will help
ensure that as many individuals and organizations as possible have
an opportunity to share comments. Commenters going over their
allotted 3-minute slot may be asked to conclude immediately in order
to allow other comments and the rest of the meeting to proceed on
schedule.
Public comment submissions received by 5:00 p.m. ET on Thursday,
March 5, 2026, will be provided to the Committee prior to the
meeting for their consideration. Any written comments received after
5:00 p.m. ET, Thursday, March 5, 2026, may be provided to the
Committee either before or after the meeting, depending on the
volume of comments received and the time required to process them in
accordance with privacy regulations and other applicable Federal
policies. The Committee is not able to respond individually to
comments. All public comments become part of the public record.
Attachments of copyrighted publications are not permitted, but web
links or citations for any copyrighted works cited may be provided.
For public comment guidelines, see: https://iacc.hhs.gov/meetings/public-comments/guidelines/.
Technical issues: If you experience any technical problems with
the webcast, please email [email protected].
Disability Accommodations: All IACC Full Committee Meetings
provide Closed Captioning through the NIH videocast
[[Page 8897]]
website. Individuals whose full participation in the meeting will
require special accommodations (e.g., sign language or interpreting
services, etc.) must submit a request to the Contact Person listed
on the notice at least seven (7) business days prior to the meeting.
Such requests should include a detailed description of the
accommodation needed and a way for the IACC to contact the requester
if more information is needed to fill the request. Special requests
should be made at least seven (7) business days prior to the
meeting; last-minute requests may be made but may not be possible to
accommodate.
Security: During the check-in process, attendees will be asked
to show one form of identification (for example, a government-issued
photo ID, driver's license, or passport) and to state the purpose of
their visit. Pre-registration is required for in-person attendance.
Meeting schedule subject to change.
More Information: Information about the IACC is available on the
website: https://iacc.hhs.gov.
Dated: February 20, 2026.
Rosalind M. Niamke,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-03684 Filed 2-23-26; 8:45 am]
BILLING CODE 4140-01-P